Evaluation of the functional activity of CD39 ectonucleotidase in regulatory T cells in children with inflammatory bowel diseases by T. V. Radygina, E. G. Sorokina, S. V. Petrichuk, D. G. Kuptsova, O. V. Kurbatova, A. S. Potapov, S. A. Afanasyeva

Subjects: Get full text

EVALUATION OF THE CONTENT OF CD4+CD25+CD127LOW REGULATORY T CELLS AND THEIR FUNCTIONAL STATUS ACCORDING TO THE EXPRESSION OF CTLA-4 AND CD39 MOLECULES IN PATIENTS WITH RHEUMATOID A... by G. A. Zhulai, E. K. Oleinik, O. Yu. Barysheva, A. V. Churov, V. M. Oleinik, P. N. Kravchenko, A. A. Kuchin

Subjects: Get full text

CD39+ conventional CD4+ T cells with exhaustion traits and cytotoxic potential infiltrate tumors and expand upon CTLA-4 blockade by Sabrina N. Bossio, Carolina Abrate, Jimena Tosello Boari, Constanza Rodriguez, Fernando P. Canale, María C. Ramello, Valentina Brunotto, Wilfrid Richer, Dario Rocha, Christine Sedlik, Anne Vincent-Salomon, Edith Borcoman, Andres Del Castillo, Adriana Gruppi, Elmer Fernandez, Eva V. Acosta Rodríguez, Eliane Piaggio, Carolina L. Montes

Subjects: Get full text

Assessment of CD4⁺ cells subpopulations with the expressing CD39 and CD73 ectonucleotidases in children with psoriasis by D. G. Kuptsova, T. V. Radigina, S. V. Petrichuk, N. N. Murashkin, A. A. Khotko, R. A. Ivanov

Subjects: Get full text

Expression of CD39 is associated with T cell exhaustion in ovarian cancer and its blockade reverts T cell dysfunction by Marius Witt, Leticia Oliveira-Ferrer, Friedrich Koch-Nolte, Stephan Menzel, Louisa Hell, Tabea Sturmheit, Elisa Seubert, Pauline Weimer, Yi Ding, Minyue Qi, Barbara Schmalfeldt, Carsten Bokemeyer, Walter Fiedler, Jasmin Wellbrock, Franziska Brauneck

Subjects: Get full text

TIM‐3 as a potential exhaustion marker in CD4+ T cells of COVID‐19 patients by Zahra Modabber, Mehdi Shahbazi, Roghayeh Akbari, Mojgan Bagherzadeh, Alireza Firouzjahi, Mousa Mohammadnia‐Afrouzi

Subjects: “…CD39…”
Get full text

Targeting the CD39/CD73 pathway: New insights into cardiac fibrosis and inflammation in female cardiac surgery patients by Eitezaz Mahmood, Mark Robitaille, Yifan Bu, Adnan Khan, Marie-France Poulin, Feroze Mahmood, Ruma Bose, Kamal R. Khabbaz, Simon C. Robson, Robina Matyal

Subjects: “…CD39…”
Get full text

Research progress of CD39-CD73-adenosine pathway in immune regulation of hepatocellular carcinoma by Lin SUN, Beili WANG, Wei GUO

Subjects: Get full text

The progress and prospects of targeting the adenosine pathway in cancer immunotherapy by Yuying Yang, Lin Zhu, Yantao Xu, Long Liang, Li Liu, Xiang Chen, Hui Li, Hong Liu

Subjects: Get full text

Endothelial -targeted CD39 is protective in a mouse model of global forebrain ischaemia by Natasha Ting Lee, Ioanna Savvidou, Carly Selan, David K. Wright, Robert Brkljaca, Joanne S.J. Chia, Ilaria Calvello, Daphne D.D. Craenmehr, Pia Larsson, Volga Tarlac, Amy Vuong, Irena Carmichael, Xiaowei Wang, Karlheinz Peter, Simon C. Robson, Harshal H. Nandurkar, Maithili Sashindranath

Subjects: Get full text

CD39 dynamics in tuberculosis: a potential biomarker of immune dysregulation and T cell exhaustion by Ling Hao, Ling Hao, Qari Muhammad Imran, Nadeem Ullah

Subjects: Get full text

CD39-Diannexin alleviates the platelet storage lesion by protecting platelets from activation, a new attempt from a traditional perspective by Cheng Liu, Peng Wang, Yafei Gao, Xiaolong Ma, Yang Su, Yao Wei, Rui Qiao

Subjects: “…CD39-Diannexin…”
Get full text

The CD39/CD73/Adenosine and NAD/CD38/CD203a/CD73 Axis in Cutaneous T-Cell Lymphomas by Liyun Lin, Gabriele Roccuzzo, Yuliya Yakymiv, Sara Marchisio, Erika Ortolan, Ada Funaro, Rebecca Senetta, Valentina Pala, Martine Bagot, Adèle de Masson, Maxime Battistella, Emmanuella Guenova, Simone Ribero, Pietro Quaglino

Subjects: Get full text

ADA/CD26 axis increases intra-tumor PD-1+CD28+CD8+ T-cell fitness and affects NSCLC prognosis and response to ICB by Ornella Franzese, Belinda Palermo, Giuseppe Frisullo, Mariangela Panetta, Giulia Campo, Daniel D’Andrea, Isabella Sperduti, Riccardo Taje, Paolo Visca, Paola Nisticò

Subjects: Get full text

Targeting CD39 boosts PD-1 blockade antitumor therapeutic efficacy via strengthening CD8 + TILs function and recruiting B cells in cervical cancer by Lili Jiang, Tong Wu, Xinyu Qu, Shuqi Li, Qi’an Jiang, Tingting Ren, Jiali Liang, Yan Ding, Keqin Hua, Zhongmin Tang, Junjun Qiu

Subjects: Get full text

Metabolic reprogramming nanomedicine potentiates colon cancer sonodynamic immunotherapy by inhibiting the CD39/CD73/ADO pathway by Yuanyuan Zhang, Weiwei Jin, Zhichao Deng, Bowen Gao, Yuanyuan Zhu, Junlong Fu, Chenxi Xu, Wenlong Wang, Ting Bai, Lianying Jiao, Hao Wu, Mingxin Zhang, Mingzhen Zhang

Subjects: Get full text